Both GSH and SOD are known to be increased in MASLD, which indicates that the levels of GSH and SOD can be used to predict the course of the disease and its progression [8,22,23,24]. The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatotic liver disease.